Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A performance comparison of heterostructure surface plasmon resonance biosensor for the diagnosis of novel coronavirus SARS-CoV-2. | Opt Quantum Electron | 2023 | 37008732 | PubTator, text mining | PubMed |
| Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells. | Front Immunol | 2023 | 37006270 | PubTator, text mining | PubMed |
| Comparison of AstraZeneca and sinopharm vaccines as boosters in protection against COVID-19 infection. | Biologicals | 2023 | 37004277 | PubTator, text mining | PubMed |
| Rabies virus-based barcoded neuroanatomy resolved by single-cell RNA and in situ sequencing. | bioRxiv | 2023 | 36993334 | PubTator, text mining | PubMed |
| Circulating Plasma Exosomal Proteins of Either SHIV-Infected Rhesus Macaque or HIV-Infected Patient Indicates a Link to Neuropathogenesis. | Viruses | 2023 | 36992502 | PubTator, text mining | PubMed |
| Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection. | Vaccines (Basel) | 2023 | 36992129 | PubTator, text mining | PubMed |
| mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown! | Vaccines (Basel) | 2023 | 36992091 | PubTator, text mining | PubMed |
| A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets. | Arch Virol | 2023 | 36988739 | PubTator, text mining | PubMed |
| Identification of SARS CoV-2 Omicron BA.1 and a novel Delta lineage by rapid methods and partial spike protein sequences in Sulaymaniyah Province, Iraq. | Immun Inflamm Dis | 2023 | 36988244 | PubTator, text mining | PubMed |
| Performance evaluation of an electrostatic precipitator with a copper plate using an aerosolized SARS-CoV-2 surrogate (bacteriophage phi 6). | Environ Technol Innov | 2023 | 36987524 | PubTator, text mining | PubMed |
| A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity. | Molecules | 2023 | 36985705 | PubTator, text mining | PubMed |
| Unveiling the Inhibitory Potentials of Peptidomimetic Azanitriles and Pyridyl Esters towards SARS-CoV-2 Main Protease: A Molecular Modelling Investigation. | Molecules | 2023 | 36985614 | PubTator, text mining | PubMed |
| Using Real-Time PCR Fluorescence Reaction Values to Improve SARS-CoV-2 Virus Detection and Benefit Clinical Decision-Making. | Life (Basel) | 2023 | 36983837 | PubTator, text mining | PubMed |
| HERVs and Cancer-A Comprehensive Review of the Relationship of Human Endogenous Retroviruses and Human Cancers. | Biomedicines | 2023 | 36979914 | PubTator, text mining | PubMed |
| Electrochemical and Bioelectrochemical Sensing Platforms for Diagnostics of COVID-19. | Biosensors (Basel) | 2023 | 36979548 | PubTator, text mining | PubMed |
| SERINC5 Mediates a Postintegration Block to HIV-1 Gene Expression in Macrophages. | mBio | 2023 | 36976020 | PubTator, text mining | PubMed |
| Diagnostic Sensitivity of Saliva and Other Respiratory Tract Samples of SARS-CoV-2 Variants in Patients with COVID-19. | Microbiol Spectr | 2023 | 36976007 | PubTator, text mining | PubMed |
| Molecular evolutionary model based on phylogenetic and mutation analysis of SARS-CoV-2 spike protein sequences from Asian countries: A phylogenomic approach. | Inform Med Unlocked | 2023 | 36974160 | PubTator, text mining | PubMed |
| Case report: Clinical course and treatment of SARS-CoV-2 in a pediatric CAR-T cell recipient with persistent hypogammaglobulinemia. | Front Pediatr | 2023 | 36969291 | PubTator, text mining | PubMed |
| Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication. | Virus Res | 2023 | 36965673 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=26